Zobrazeno 1 - 10
of 215
pro vyhledávání: '"Michael, Lein"'
Autor:
Angelika Tölle, Andreas Maxeiner, Carsten Stephan, Frank Friedersdorff, Michael Lein, Klaus Jung, Annika Fendler
Publikováno v:
Cancer Biomarkers. 30:381-393
BACKGROUND: There is an urgent need for better prostate cancer (PCa) biomarkers due to the low specificity of prostate specific antigen (PSA). OBJECTIVE: Prostate Health Index (PHI) is an advanced PSA-based test for early detection of PCa. The presen
Autor:
Michael Lein, Andreas Maxeiner, Frank Friedersdorff, Klaus Jung, Carsten Stephan, Hannah Rochow
Publikováno v:
World Journal of Urology
Purpose To evaluate the Prostate Health Index (PHI) density (PHID) in direct comparison with PHI in a prospective large cohort. Methods PHID values were calculated from prostate-specific antigen (PSA), free PSA and [− 2]proPSA and prostate volume.
Publikováno v:
Cancers; Volume 14; Issue 6; Pages: 1560
There are limited and discrepant data on prostate cancer (PCa) and vitamin D. We investigated changes in three vitamin D3 metabolites in PCa patients after prostatectomy with zoledronic acid (ZA) treatment regarding their metastasis statuses over fou
Autor:
Carsten Stephan, Robert Peters, Andreas Maxeiner, Frank Friedersdorff, Michael Lein, Klaus Jung
Background: Beyond prostate-specific antigen (PSA), other biomarkers for prostate cancer (PCa) detection are available and need to be evaluated for clinical routine. Objective: The aim of the study was to evaluate the Prostate Health Index (PHI) dens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b13735567a3815792f44ad71ad4df83e
https://doi.org/10.1159/000517891
https://doi.org/10.1159/000517891
Autor:
Neira Gamboa, Klaus Jung, Milagros Avendaño, Katiuska Charris, Gricelda Mata, Michael Lein, Michael Höpfner, Melina Monasterios, Juan Rodrigues, Gricela Lobo, Claudia Abramjuk, Bianca Nitzsche, Jaime Charris
Publikováno v:
Letters in Drug Design & Discovery. 14:398-413
Autor:
Sandra González Maldonado, Matteo Montani, Hellmuth A. Meyer, Sebastian Meller, Regina Reszka, Klaus Jung, Dimo Dietrich, Bianca Bethan, Philipp Schatz, Erik Peter, Carsten Stephan, Michael Lein, Glen Kristiansen, Beate Kamlage
Publikováno v:
Oncotarget
Integrated analysis of metabolomics, transcriptomics and immunohistochemistry can contribute to a deeper understanding of biological processes altered in cancer and possibly enable improved diagnostic or prognostic tests. In this study, a set of 254
Publikováno v:
Clinical Biochemistry. 47:916-920
Prostate cancer (PCa) detection suffers from low specificity when using the prostate-specific antigen (PSA) alone. The aim of this study was to investigate the applicability of total testosterone (tT), free testosterone (fT), the fraction (%) of fT t
Autor:
John Buckendahl, Carsten Stephan, Ahmed Magheli, Hellmuth-Alexander Meyer, Kristin Hamborg, Kurt Miller, Jonas Busch, Klaus Jung, Michael Lein
Publikováno v:
Journal of Urology. 188:2165-2170
Limited data exist on the relationship of percent free prostate specific antigen and prostate specific antigen density with prostate cancer prognosis. Therefore, we compared percent free prostate specific antigen and prostate specific antigen density
Autor:
Carsten Stephan, Ergin Kilic, Jonas Busch, Michael Lein, Julia Matalon, Zhongwei Zhao, Klaus Jung
Publikováno v:
The Journal of urology. 196(3)
We evaluated the usefulness of serum 25-hydroxyvitamin D as a marker of aggressive prostate cancer and for active surveillance compared to PHI (Prostate Health Index).Of 480 prospectively biopsied men 222 had prostate cancer and 258 had no evidence o
Autor:
Ahmed Magheli, Anja Herold, Kurt Miller, Michael Lein, Steffen Weikert, Stefan Hinz, Jonas Busch, Carsten Kempkensteffen, Barbara Erber, Carsten Stephan
Publikováno v:
BJU International. 110:E985-E990